Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

590 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Welcome to the preexposure prophylaxis revolution.
Baeten J, McCormack S. Baeten J, et al. Curr Opin HIV AIDS. 2016 Jan;11(1):1-2. doi: 10.1097/COH.0000000000000225. Curr Opin HIV AIDS. 2016. PMID: 26633637 No abstract available.
Oral antiretroviral chemoprophylaxis: current status.
Baeten J, Celum C. Baeten J, et al. Curr Opin HIV AIDS. 2012 Nov;7(6):514-9. doi: 10.1097/COH.0b013e3283582d30. Curr Opin HIV AIDS. 2012. PMID: 22964886 Free PMC article. Review.
Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women.
Mugwanya K, Baeten J, Celum C, Donnell D, Nickolas T, Mugo N, Branch A, Tappero J, Kiarie J, Ronald A, Yin M, Wyatt C; Partners PrEP Study Team. Mugwanya K, et al. Among authors: baeten j. J Infect Dis. 2016 Oct 1;214(7):1050-7. doi: 10.1093/infdis/jiw125. Epub 2016 Mar 29. J Infect Dis. 2016. PMID: 27029778 Free PMC article. Clinical Trial.
Meet the Editors.
Zablotska I, Baeten J, Phanuphak N, McCormack S, Ong J. Zablotska I, et al. Among authors: baeten j. Sex Health. 2018 Nov;15(6):i-iii. doi: 10.1071/SHv15n6_MeetED. Sex Health. 2018. PMID: 30496715 No abstract available.
HIV-1 Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-Exposure Prophylaxis: Pooled Analysis From 72 Global Studies.
Landovitz RJ, Tao L, Yang J, de Boer M, Carter C, Das M, Baeten JM, Liu A, Hoover KW, Celum C, Grinsztejn B, Morris S, Wheeler DP, Mayer KH, Golub SA, Bekker LG, Diabaté S, Hoornenborg E, Myers J, Leech AA, McCormack S, Chan PA, Sweat M, Matthews LT, Grant R; Global F/TDF PrEP Study Team. Landovitz RJ, et al. Among authors: baeten jm. Clin Infect Dis. 2024 Mar 14:ciae143. doi: 10.1093/cid/ciae143. Online ahead of print. Clin Infect Dis. 2024. PMID: 38484128
Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
Mujugira A, Baeten JM, Donnell D, Ndase P, Mugo NR, Barnes L, Campbell JD, Wangisi J, Tappero JW, Bukusi E, Cohen CR, Katabira E, Ronald A, Tumwesigye E, Were E, Fife KH, Kiarie J, Farquhar C, John-Stewart G, Kidoguchi L, Panteleeff D, Krows M, Shah H, Revall J, Morrison S, Ondrejcek L, Ingram C, Coombs RW, Lingappa JR, Celum C; Partners PrEP Study Team. Mujugira A, et al. Among authors: baeten jm. PLoS One. 2011;6(10):e25828. doi: 10.1371/journal.pone.0025828. Epub 2011 Oct 5. PLoS One. 2011. PMID: 21998703 Free PMC article. Clinical Trial.
590 results